Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah's Witnesses.
CONCLUSION: ASCT can safely be performed without transfusion support. A platelet transfusion trigger of ≤ 5 × 10(3)/μL may be appropriate in select patients. Pharmacotherapy and cardiac monitoring are effective in the management of cardiac complications.
PMID: 25870085 [PubMed - as supplied by publisher]
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Ford PA, Grant SJ, Mick R, Keck G Tags: J Clin Oncol Source Type: research
More News: Amyloidosis | Bleeding | Cancer & Oncology | Chemotherapy | Grants | Hematology | Kidney Transplant | Kidney Transplantation | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Study | Transplants | Urology & Nephrology